Heartburn medication Zantac recalled due to possible contamination
Residents who own this over-the-counter medication may want to refrain from using it, at least for the time being.
Pharmaceutical company Sanofi announced today that it's recalling heartburn medication Zantac as a precaution "due to potential contamination with a nitrosamine impurity called N-nitrosodimethylamine (NDMA)".
The voluntary recall is in effect in Canada and the US.
The recall comes more than a month after Health Canada and the US Food and Drug Administration reported in September that some ranitidine medicines, including Zantac, could contain NDMA at low levels.
Manufacturers of these medicines have been asked to conduct testing to ensure the safety of the product.
Sanofi has chosen to recall the medication as evaluations continue on both the drug substance (active ingredient) and the finished drug product.
Anyone using Zantac is encouraged to contact their doctor or pharmacist with any questions.
- Ontario extends business closures amid COVID-19 crisis
- Ontario reports over 450 new COVID-19 cases, 100 cases confirmed in Halton
- Internet providers explain why they’ve hiked prices amid an economic downturn
- Halton police ramp up COVID-19 compliance enforcement with new powers
- All Burlington parks closed to vehicular access in response to COVID-19
- Popular Flour Product Recalled for Contamination with Harmful Bacteria
- Chicken Product Recalled Due to Potential Contamination in Halton
- Bean sprouts product recalled due to possible Salmonella contamination
- Baby formula recalled due to possible contamination
- Peanut spread recalled due to possible Listeria contamination: CFIA